References
I. E. Kovalev,Khim.-Farm Zh.,11(12), 3–14 (1977).
D. R. Nelson, T. Kamataki, D. J. Waxman, et al.,DNA Cell Biol.,12(1), 1–51 (1993).
I. E. Kovalev,Priroda, No. 7, 69–77 (1981).
I. E. Kovalev and O. Yu. Polevaya,Biochemical Backgrounds of Immunity to Low-Molecular-Weight Compounds [in Russian], Nauka, moscow (1985).
I. E. Kovalev,Proc. 1st Int. Workshop: Bio-Molecular Medicine-2000: in Search of Approaches” [in Russian], Moscow (1963), pp. 12–19.
I. E. Kovalev, E. I. Musabaev, and M. D. Akhmedova,Immunochemical Functional System of Homeostasis During Infection-Induced and Noninfection Pathology [in Russian], Navruz, Tashkent (1944).
I. E. Kovalev and O. Yu. Polevaya,Antibodies to Physiologically Active Compounds [in Russian], Meditsina, Moscow (1981).
I. E. Kovalev and N. V. Shipulina,Izv. Akad. Nauk SSSR, Ser. Biol., No. 1, 31–40 (1992).
I. E. Kovalev,Khim.-Farm. Zh.,23(12), 1413–1424 (1989).
I. E. Kovalev,Abstracts of Papers. The 12th Int. Symp. on Medical Chemistry, Basel (1992), p. 21.
I. E. Kovalev,Absracts of Papers. The 12th Eur. Workshop on Drug Metabolism, Patri (1994), L18, p. 185.
I. E. Kovalev and N. V. Shipulina,Khim.-Farm. Zh.,30(1), 3–8 (1996).
M. G. Belvisi,Eur. J. Pharmacol.,210(2), 221–222 (1992).
D. S. Bredt, Ch. E., Glatt, P. M. Hwang, et al.,Neuron,7, 615–624 (1991).
D. S. Bredt and S. H. Snyder,Neuron,8, 3–11 (1992).
O. G. Khatsenko S. S. Gross, A. B. Rifkind, and J. R. Vane,Proc. Natl. Acad. Sci. USA,90(23), 11147–11151 (1993).
J. F. Ewing,Methods of Neurosciences, Vol. 31. Nitric Oxide Synthase: Characterization and Functional Analysis, N. D. Maines (eds.), Acad. Press, SanDiego, London, New York (1996), p. 112.
D. W. Nebert and J. E. Gielen,Fed. Proc.,31(4), 1315–1325 (1972).
I. E. Kovalev and N. V. Shipulina,Khim.-Farm. Zh.,22(1), 5–9 (1988).
I. E. Kovaev, L. A. Piruzyan, V. A. Shaternikova, et al.,Dokl. Akad. Nauk SSSR,266(1), 247–249 (1982).
I. E. Kovalev, T. G. Khlopushina, R. G. Azizov, et al.,Absracts of Papers. The 3rd Al-Union Congr. Pathophysiologists “Damage and Regulatory Processes in the Organism” [in Russian], Tbilisi (1982), p. 19.
I. E. Kovalev, T. G. Khlopushina, I. N. Marokko, et al.,Patol. Fiziol. Eksp. Terap., No. 4, 22–25 (1983).
R. A. Pittner and J. A. Stitzer,Biochem. Biophys. Res. Commun.,185, 430–435 (1992).
R. E. Ebel, D. H. O'Keefe, and J. A. Peterson,FEBS Letter,55, 198–201 (1975).
R. K. W. el Azhary and G. J. Mannering,Mol. Pharmacol.,15, 698–707 (1979).
R. K. W. el Azhary, K. W. Renton, and G. J. Mannering,Mol. Pharmacol.,17(3), 395–399 (1980).
I. E. Kovalev and R. G. Azizov,Farmakol. Toksikol., No. 1, 5–13 (1986).
A. Poland and E. Govier,Science,179, 476–477 (1973).
D. E. Metzler,The Chemical Reactions of Living cells, Acad. Press, New York (1977).
C. O. Heocha, in:Porphyrins and Related Compounds, T. W. Goodwin (ed.), Acad. Press, New York (1969), pp. 91–105.
R. Tenhunnen, H. Marver, N. R. Pinstone, et al.,Biochemistry,11, 1716–1720 (1972).
M. D. Maines and A. Kappas,Proc. Natl. Acad. Sci. USA,71, 4283–4287 (1974).
N. R. Prabhakar,Respir. Physiol.,114(1), 57–64 (1998).
I. Horvath,Thorax,53(8), 668–672 (1998).
G. E. R. Hook and J. R. Bend,Life Sci.,18(3), 279–290 (1976).
S. R. Slaughter, C. R. Wolf, J. P. Martciniszyn, and R. M. Philpot,Environ. Health Perspect.,33, 327 (1979).
S. R. Slaughter, C. R. Wolf, J. P. Marzcinzyn, and R. M. Philpot,J. Biol. Chem.,256, 2499–2503 (1981).
R. M. Philpot and C. R. Wolf,Reviews in Biochemical Toxicology, E. Hodgson, J. R. Bend, and R. M. Philpot (eds.),3, 51–75 (1981).
Y. Kitagava, M. Okamoto, and T. Sugiyama,Arch. Toxicol,59, 1–3 (1986).
R. W. Teel,Cancer Lett.,7(6), 349–335 (1979).
P. G. Gervasi and V. Longo,Abstracts of 14th Eur. Workshop on Drug Metabolism, Paris (1994), L38, p. 51.
E. Arinc,Cytochrome P450, J. B. Schenkman and H. Greim (eds.), Springer-Verlag, Berlin (1993), pp. 373–386.
T. A. Flak and W. E. Goldman,Am. J. Respir. Crit. Care Med.,154, 202–206 (1996).
M. R. Hill, R. D. Stith, and R. E. McCallum,J. Immunol.,137(3), 858–862 (1986).
N. Warrenn,Ann. N. Y. Acad. Sci.,278, 15 (1976).
D. Farquhar, T. L. Loo, J. U. Gutterman, et al.,Biochem. Pharmacol.,25, 1529–1535 (1976).
N. R. Mettler, S. Yano, and Y. Kikkawa,Biochem. Pharmacol.,36(22), 3873–3878 (1987).
D. E. Williams, S. E. Hale, R. T. Okita, and B. S. S. Masters,J. Biol. Chem.,259, 14600–14608 (1984).
S. Matsubara, S. Yamamoto, K. Sogawa, et al.,J. Biol. Chem.,262, 13366–13371 (1987).
R. M. Philpot, R. Gasser, and M. P. Lawton, in:Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds, E. Arnic, J. B. Schenkman, and E. Hodgson (eds.), New York (1991), pp. 55–73.
C. J. Serabjit-Singh, T. R. Devereux, J. R. Fouts, and R. M. Philpot,Biochemistry, Biophysic sand Regulation of Cytochrome P-450, J. A. Gustafsson, J. Carlstedt-Duke, A. Mode, and J. Rafter (eds.), Elsever, North Holland, Amsterdam (1980), pp. 451–454.
R. M. Philpot, C. R. Wolf, S. R. Slaughter, et al., in:Microsomes, Drug Oxidation and Drug Toxicity, R. Sato and R. Kato (eds.), Jpn. Sci. Soc. Press, Tokio (1982), pp. 487–494.
J. Schneyder and M. J. Baggioulini,J. Exp. Med.,148, 435 (1978).
V. L. Kovaleva, A. G. Chuchalin, and N. A. Kolganova,Pul'monologiya, No. 1, 79–87 (1988).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 33, No. 9, pp. 3–7, September, 1999.
Rights and permissions
About this article
Cite this article
Kovalev, I.E., Kovaleva, V.L. The role of the immunochemical functional homeostasis system in the search for new pharmacological means of treatment of respiratory tract diseases. Pharm Chem J 33, 461–466 (1999). https://doi.org/10.1007/BF02510068
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02510068